Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Identification Of New Asthma Genes Demonstrates A Model For Improved Patient Care

13.04.2004


An international team of researchers from the University of Helsinki, GeneOS Ltd. and partner institutions announced today that it has made significant discoveries on the causes of asthma. The team’s study, published in the April 9, 2004 edition of Science, reports two novel asthma genes and a set of diagnostic single nucleotide polymorphisms (SNPs).

The implications of the finding are that physicians may be able to identify atopic asthma and allergy patients earlier than is currently possible. Even more importantly, the gene that was found to be the risk gene for asthma is well suited for a drug target molecule.
Previous genome-wide scans in multiple populations have suggested that there is a susceptibility region for asthma on chromosome 7p. This study focused its efforts to confirm the hypothesis and to identify the genes in the Finnish families. The results were then replicated among the Canadian families to be sure that the findings are valid also in other populations. A hierarchical genotyping design was used and lead to the identification of a 133kb risk-conferring segment that contained two genes. The data imply that an orphan G-protein receptor named GPRA is involved in the pathogenesis of atopy and asthma and may have application in other inflammatory diseases.


“The importance of this discovery is that our findings validate our approach of being able to build relevant patient databases and use this information to understand disease outcome”, said Tarja Laitinen, Chief Scientific Officer, GeneOS. “Additionally, these findings are very relevant for our company because they show how we can use information generated in Finland and apply it to other populations. GeneOS is building its capabilities to study disease outcomes in Finland to help pharmaceutical and medical device companies design and run clinical trials and better understand patient response. Findings like the GPRA gene will lead to better diagnosis and treatment.”

“This research is a culmination of ten-year project to identify genes for complex diseases”, said Professor Juha Kere from Karolinska Institutet (Sweden) and University of Helsinki. “Other, similar findings may become reality from comparable efforts, building on the excellent Finnish and Scandinavian medical and population data.”

The number of asthmatics has been growing at about 10 % per year; currently asthma affects approximately 6-10 % of the population in the United States and Western Europe. Asthma accounts for approximately 10 % of all prescription drug spending in the United States and Western Europe. Treatment plans are complex and the ability to measure improved outcome is poor. The ability to study outcomes in Finland and then confirm the findings in other populations will help improve treatment for patients worldwide.

For further information please contact:
Juha Kere, Professor, Helsinki University and Karolinska Institutet, +46 7 3421 3550, juha.kere@biosci.ki.se (about discovery)

Tarja Laitinen, Chief Scientific Officer, GeneOS Ltd., + 358 50 534 6238,tarja.laitinen@geneos.fi (about discovery and GeneOS)

Steve Lehrer, CEO, GeneOS Inc. +1 650 269 3420,
steve@sblehrer.com (about GeneOs)

Paivi Lehtinen | alfa
Further information:
http://www.helsinki.fi

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>